Cargando…

A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment

BACKGROUND: In 2011, World Health Organization revised its recommendation for microbiological monitoring during treatment for multidrug-resistant tuberculosis (MDR-TB) by increasing the frequency of culture examination from quarterly to monthly after culture conversion. Implementing the recommendati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Chunling, Liu, Qing, Sarma, Aartik, Fitzpatrick, Christopher, Falzon, Dennis, Mitnick, Carole D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574085/ https://www.ncbi.nlm.nih.gov/pubmed/23457502 http://dx.doi.org/10.1371/journal.pone.0056074

Ejemplares similares

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Multidrug-Resistant Tuberculosis, Somalia, 2010–2011
por: Sindani, Ireneaus, et al.
Publicado: (2013)

Long-term Follow-up for Multidrug-resistant Tuberculosis
por: Shin, Sonya S., et al.
Publicado: (2006)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
por: Cox, Helen S, et al.
Publicado: (2015)

Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
por: Tierney, Dylan B., et al.
Publicado: (2016)

Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment
por: Tierney, Dylan B., et al.
Publicado: (2014)

Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now
por: Mitnick, Carole D, et al.
Publicado: (2007)

Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia
por: Shibabaw, Agumas, et al.
Publicado: (2018)

Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
por: Rodriguez, Carly A., et al.
Publicado: (2022)

Multidrug-resistant Tuberculosis in Central Asia
por: Cox, Helen Suzanne, et al.
Publicado: (2004)

Multidrug-resistant tuberculosis in children: evidence from global surveillance
por: Zignol, Matteo, et al.
Publicado: (2013)

Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis
por: Alene, Kefyalew Addis, et al.
Publicado: (2018)

Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts
por: Brooks, Meredith B., et al.
Publicado: (2018)

Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis
por: Byrne, Anthony L., et al.
Publicado: (2017)

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants
por: Odone, Anna, et al.
Publicado: (2016)

Use of a Molecular Diagnostic Test in AFB Smear Positive Tuberculosis Suspects Greatly Reduces Time to Detection of Multidrug Resistant Tuberculosis
por: Tukvadze, Nestani, et al.
Publicado: (2012)

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method
por: Mitnick, Carole D., et al.
Publicado: (2016)

Sputum Smear and Culture Conversion in Multidrug Resistance Tuberculosis Patients in Seven Districts of Central Gujarat, India: A Longitudinal Study
por: Patel, Sangita V., et al.
Publicado: (2018)

Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis
por: Fox, Gregory J., et al.
Publicado: (2016)

Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia
por: Brhane, Mussie, et al.
Publicado: (2017)

Determining Mycobacterium tuberculosis Drug Resistance and Risk Factors for Multidrug-Resistant Tuberculosis in Sputum Smear-Positive Tuberculosis Outpatients in Anhui Province, China, 2015–2016
por: Yao, Song, et al.
Publicado: (2020)

Prolongation of Acid-Fast Bacilli Sputum Smear Positivity in Patients with Multidrug-Resistant Pulmonary Tuberculosis
por: Mvo, Sidwell, et al.
Publicado: (2023)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

Multidrug-resistant Tuberculosis Management in Resource-limited Settings
por: Nathanson, Eva, et al.
Publicado: (2006)

Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis
por: Resch, Stephen C, et al.
Publicado: (2006)

Multidrug-resistant tuberculosis around the world: what progress has been made?
por: Falzon, Dennis, et al.
Publicado: (2015)

Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis
por: Singh, Binit Kumar, et al.
Publicado: (2017)

Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis
por: Kipiani, Maia, et al.
Publicado: (2021)

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Trauer, James M., et al.
Publicado: (2016)

Correction to: Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis
Publicado: (2022)

Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia
por: Sinshaw, Waganeh, et al.
Publicado: (2019)

Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
por: Chen, Jun, et al.
Publicado: (2017)

Magnitude of Multidrug Resistance and Associated Factors of Pulmonary Tuberculosis Among Adult Smear Positive Patients in Eastern Ethiopia
por: Amin, Ziad, et al.
Publicado: (2021)

The Reductionist Conundrum of an “Updated” Definition of Extensively Drug-Resistant Tuberculosis
por: Mitnick, Carole D., et al.
Publicado: (2021)

Measuring the accuracy of a point system to diagnose tuberculosis in children with a negative smear or with no smear or culture
por: Braga Cartaxo, Constantino Giovani, et al.
Publicado: (2014)

Smears and cultures for diagnosis of pulmonary tuberculosis in an asymptomatic immigrant population
por: Assael, Roberto, et al.
Publicado: (2013)

Comparison of culture, microscopic smear and molecular methods in diagnosis of tuberculosis
por: Afsar, Ilhan, et al.
Publicado: (2018)

Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update
por: Diel, Roland, et al.
Publicado: (2020)

1881. Costs of Treating Multidrug Resistant Tuberculosis in California, 2022
por: Katrak, Shereen, et al.
Publicado: (2023)

Psychological costs of inadequate cervical smear test results
por: French, D P, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_f0h79u0unm022gbtid4ld5kknn